heartware today passed the $100 barrier which made me think...

heartware today passed the $100 barrier which made me think about some of the similarities with SSH and where we should be right now and where we should be years down the line .

heartware recieved fda approval in november 2012 , however they reached $99 in january 2011 thats almost 2 years before they gained fda approval !

im not trying to be impatient or greedy , but how on earth are we this low stock price wise ?

weve got a superior product which can be the standard care
untapped larger market
other markets potential - angina
patients weaning off the device + reversal of heart failure
enough cash to go the trial alone
all insiders excercised their options with hefty holdings
2 largest shareholders doubling their shares in the company
expansion of SSH team to include more experience+expertise
poison pill in place to ward off suitors / buyout talk


what are we waiting for ? does the market know something we dont ? are our ambitions and targets un-realistic ?

what news will propel the stock price to a level that mirrors progress

weve had very good news with minimal impact on the stock price , even the tct meeting which in all honesty was very very positive , we had a 3-4 dollar setback after the tct

we all share the same goal and hope with SSH , but no1 can deny the frustration so far . yes its a great opportunity to add to your position , but aren't we past the stage where its all potential with a very low valuation etc


dont get me wrong , im really impressed with the steps taken by management . the poison pill to the financings to ensure SSH can go it all the way , to the addition of experienced staff to overlook the trials , everything that has happened over the past 12 months has been very very good and my single SSH holding in my portfolio is testament to the faith i have in the product and management.

to think that heartware can reach $99 2 years before fda approval , and sunshine heart with a life changing device ,a technology which is safer more affordable and non-blood contacting , were 10% the stock price and the market cap of heartware

if heartware can reach $100 , then think 3 years ahead , if we do gain fda approval if we do manage to commercialize the cpulse 2 , if we do gain a big share of the market and tap into other markets , arent we supposed to be a couple of times bigger than heartware ? when you imagine all the numbers and the potential ud think we should be in triple digits down the line .

and yet were half way there or a third of the way there and were languishing at 10 dollars .




just would like to see signs that the company will aim for the stars with this product , would be sad to be sold down the line with a 400% 500% on todays prices.

call me greedy call me impatient , were nowhere near were we should be.